healthcare < healthy < hearing

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000201 (2014)	Kosmas Kretsos [Royaume-Uni] ; Georg Golor [Allemagne] ; Astrid Jullion [Belgique] ; Matthew Hickling [Royaume-Uni] ; Suzanne Mccabe [Belgique] ; Stevan Shaw [Royaume-Uni] ; Joby Jose [Royaume-Uni] ; Ruth Oliver [Royaume-Uni]	Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study
000283 (2011)	A. Arman [Turquie] ; A. Coker [Turquie] ; O. Sarioz [Turquie] ; N. Inanc [Turquie] ; H. Direskeneli [Turquie]	Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population
000292 (2010)	W. Graninger [Autriche]	Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis
000298 (2012)	Yin Liu [États-Unis] ; Yuval Ramot [Israël] ; Antonio Torrelo [Espagne] ; Amy S. Paller [États-Unis] ; Nuo Si [République populaire de Chine] ; Sofia Babay [Israël] ; Peter W. Kim [États-Unis] ; Afzal Sheikh [États-Unis] ; Chyi-Chia Richard Lee [États-Unis] ; Yongqing Chen [États-Unis] ; Angel Vera [Espagne] ; Xue Zhang [République populaire de Chine] ; Raphaela Goldbach-Mansky [États-Unis, Israël] ; Abraham Zlotogorski [Israël]	Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity
000421 (2013)	P. N. Morcos [États-Unis] ; S. A. Moreira [États-Unis] ; B. J. Brennan [États-Unis] ; S. Blotner [États-Unis] ; N. S. Shulman [États-Unis] ; P. F. Smith [États-Unis]	Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate
000457 (2013)	C. Guillou ; G. Avenel ; C. Derambure ; M. Verdet ; M.-L. Golinski ; M. Hiron ; S. Adriouch ; O. Boyer [France] ; T. Lequerré ; O. Vittecoq	AB0305 Potential in vitro immunomodulatory effects of the recombinant human alpha-enolase on peripheral blood mononuclear cells (pbmcs) from healthy donors.
000468 (2013)	T. Tsuru ; M. Suzaki ; K. Maeda ; H. Nakashima ; T. Eto ; M. Ishibashi ; J. Manabe ; K. Terao [Japon] ; S. Irie	AB0580 Selological responce of the H1N1PDM influenza vaccine in patients with rheumatoid arthritis treated with monoclonal antibody therapy or conventional DMARDS, comparison with healthy adult
000512 (2010)	Aharon Kessel [Israël] ; Regina Peri [Israël] ; Tharwat Haj [Israël] ; Ayelet Snir [Israël] ; Gleb Slobodin [Israël] ; Edmond Sabo [Israël] ; Itzhak Rosner [Israël] ; Yehuda Shoenfeld [Israël] ; Elias Toubi [Israël]	IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
000568 (2014)	Koji Chiba [Japon] ; Hiroyuki Yoshitsugu [États-Unis] ; Yuto Kyosaka [Japon] ; Satofumi Iida [Japon] ; Koichiro Yoneyama [Japon] ; Takahiko Tanigawa [Allemagne] ; Takashi Fukushima [Japon] ; Masaki Hiraoka [Japon]	A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?
000654 (2013)	U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]	SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
000825 (2013)	N. Al Kotbi [Pays-Bas] ; L. Jensen ; L. B. Graff [Danemark]	FRI0196 NNC0109-0012 (anti-IL-20 MAB), well tolerated in healthy subjects and patients with rheumatoid arthritis
000A45 (2012)	Chunhua Xun [République populaire de Chine] ; Yong Zhao [République populaire de Chine] ; Zhi Jian Hu [République populaire de Chine]	Potential role of adenosine deaminase in the diagnosis of adult-onset Still’s disease
000A46 (2013)	Gleb Slobodin [Israël] ; Lisa Kaly [Israël] ; Regina Peri [Israël] ; Aharon Kessel [Israël] ; Itzhak Rosner [Israël] ; Elias Toubi [Israël] ; Doron Rimar [Israël] ; Nina Boulman [Israël] ; Michael Rozenbaum [Israël] ; Majed Odeh [Israël]	Higher Expression of Latency-Associated Peptide on the Surface of Peripheral Blood Monocytes in Patients with Rheumatoid Arthritis may be Protective Against Articular Erosions
000A48 (2010)	Maria José Santos [Portugal] ; Diana Fernandes [Portugal] ; Susana Capela [Portugal] ; Jose Canas Da Silva [Portugal] ; João Eurico Fonseca [Portugal]	Interleukin-6 promoter polymorphism −174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients
000A57 (2011)	Mara Anaís Llamas-Covarrubias [Mexique] ; Yeminia Valle [Mexique] ; Rosa Elena Navarro-Hernández [Mexique] ; Iris Paola Guzmán-Guzmán [Mexique] ; María Guadalupe Ramírez-Due As [Mexique] ; Héctor Rangel-Villalobos [Mexique] ; Ciro Estrada-Chávez [Mexique] ; José Francisco Mu Oz-Valle [Mexique]	Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
000B18 (2013)	S. Perrier D Auterive [Belgique] ; S. Kesseler [Belgique] ; P. Ruggeri [Belgique] ; M. Timmermans [Belgique] ; O. Gaspard [Belgique] ; T. Kumke [Allemagne] ; G. Parker [Royaume-Uni]	FRI0160 Certolizumab PEGOL did not result in a decrease in semen quality in healthy volunteers: Results from a phase 1 study
000B23 (2012)	Justin Gillespie [Royaume-Uni] ; Sinisa Savic [Royaume-Uni] ; Chi Wong [Royaume-Uni] ; Aiden Hempshall [Royaume-Uni] ; Martyn Inman [Royaume-Uni] ; Paul Emery [Royaume-Uni] ; Ronald Grigg [Royaume-Uni] ; Michael F. Mcdermott [Royaume-Uni]	Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin‐6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients
000C29 (2013)	Y. Maeda ; M. Matsushita ; A. Yura ; S. Teshigawara ; M. Katayama ; M. Yoshimura ; A. Watanabe ; E. Tanaka ; S. Tsuji ; A. Kitatobe ; Y. Harada ; S. Ohshima ; Y. Katada ; J. Hashimoto ; K. Ogata [Japon] ; T. Takahashi [Japon] ; H. Tsuji [Japon] ; K. Nomoto [Japon] ; A. Kumanogoh ; K. Takeda ; Y. Saeki	OP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics
000C68 (2013)	Min Ni [République populaire de Chine] ; Wei Wei [République populaire de Chine] ; Yichao Wang [République populaire de Chine] ; Na Zhang [République populaire de Chine] ; Hongmei Ding [République populaire de Chine] ; Chen Shen [République populaire de Chine] ; Fang Zheng [République populaire de Chine]	Serum Levels of Calreticulin in Correlation with Disease Activity in Patients with Rheumatoid Arthritis
000C72 (2011)	P. Drastich [République tchèque] ; L. Frolova-Brizova [République tchèque] ; P. Zanvit [République tchèque] ; J. Spicak [République tchèque] ; H. Tlaskalova-Hogenova [République tchèque]	Spontaneous in vitro IL-6 production in various intestinal segments in patients with inflammatory bowel disease
000C77 (2008)	Ingo H. Tarner [Allemagne] ; Ulf Müller-Ladner [Allemagne] ; Christine Uhlemann [Allemagne] ; Uwe Lange [Allemagne]	The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "healthy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "healthy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    healthy
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021